What is a billable diagnosis for a stable adult patient with Major Depressive Disorder (MDD) being treated with antidepressants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Billable Diagnosis for Stable MDD on Antidepressants

For a stable adult patient with Major Depressive Disorder being treated with antidepressants, the appropriate billable diagnosis is F33.41 (Major depressive disorder, recurrent, in remission) if this represents a recurrent episode, or F32.5 (Major depressive disorder, single episode, in full remission) if this is the first episode.

Understanding Treatment Phases and Diagnostic Coding

The treatment of MDD follows three distinct phases that determine appropriate diagnostic coding 1:

  • Acute phase (6-12 weeks): Initial treatment period 1
  • Continuation phase (4-9 months): Period after initial response where relapse prevention is critical 1
  • Maintenance phase (≥1 year): Long-term management for stable patients 1

A "stable" patient on antidepressants is typically in the continuation or maintenance phase, having achieved response (≥50% reduction in symptom severity) or remission (absence of significant symptoms). 1, 2

Selecting the Correct ICD-10 Code

For Patients in Full Remission:

  • F32.5: Major depressive disorder, single episode, in full remission (first episode) 2
  • F33.41: Major depressive disorder, recurrent, in full remission (history of prior episodes) 2

For Patients in Partial Remission:

  • F32.4: Major depressive disorder, single episode, in partial remission 2
  • F33.40: Major depressive disorder, recurrent, in partial remission 2

For Patients Still Symptomatic but Stable:

  • F33.1: Major depressive disorder, recurrent, moderate (if symptoms persist but are controlled) 2

Key Clinical Considerations

Treatment should be continued for at least 4-9 months after satisfactory response for first episodes, with longer duration (≥1 year) beneficial for recurrent episodes. 2, 3 This means even "stable" patients require ongoing treatment and appropriate diagnostic coding to justify continued antidepressant therapy 2.

Common Pitfall to Avoid:

Do not prematurely code as "in remission" if the patient has not completed the recommended continuation phase duration, as this may lead to insurance denials for ongoing medication coverage 2. The patient must demonstrate sustained symptom improvement for an adequate period before coding as remission 2.

Documentation Requirements

To support the billable diagnosis, document:

  • Current symptom status using validated tools (PHQ-9 or HAM-D scores) 1, 2
  • Duration of current treatment phase 1
  • Whether this represents first episode or recurrent depression 2
  • Ongoing need for maintenance therapy to prevent relapse 2, 4

For insurance purposes, "stable on antidepressants" typically means the patient is in partial or full remission but requires ongoing pharmacotherapy to maintain stability, justifying continued treatment and medication coverage. 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria and Treatment Options for Major Depressive Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Depression in Young Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the best step to ensure confidentiality for a 20-year-old female patient with major depressive disorder (MDD) symptoms, including suicidal ideation, who has discontinued her medications?
What treatment approach should be taken for a 21-year-old female with major depressive disorder and adjustment disorder with mixed anxiety and depressed mood who stopped her medications, including selective serotonin reuptake inhibitors (SSRIs) like sertraline (Zoloft) or fluoxetine (Prozac), and is now experiencing insomnia?
How to manage a 30-year-old man with major depressive disorder on SSRI 200mg daily experiencing anorexia, fatigue, and excessive sleep?
What is the next safest treatment option for a 70-year-old female with depression who experienced adverse effects with Sertraline (Zoloft), a Selective Serotonin Reuptake Inhibitor (SSRI)?
What is the recommended first-line medication treatment for a 15-year-old with major depression?
What serology tests are recommended for a pregnant woman of childbearing age with no prior prenatal care?
What are the treatment options for an adult newly diagnosed with lymphoma?
What's the next step for an adult patient with schizophrenia and significant extrapyramidal side effects, who doesn't respond to reduced antipsychotic medication (e.g. risperidone or olanzapine) and addition of trihexyphenidyl 4mg?
Is there a role for Platelet-Rich Plasma (PRP) therapy in a 45-year-old female patient with mild Acromioclavicular (AC) joint arthropathy and signs suggestive of frozen shoulder?
What is the recommended diagnostic approach for a patient suspected of having lymphoma?
Is it safe to prescribe Augmentin (amoxicillin/clavulanate) to elderly patients taking rosuvastatin (a statin)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.